Stockreport

NRx Pharmaceuticals (NASDAQ:NRXP) Announces Development of New, Proprietary Formulation of HTX-100 (IV Ketamine) [Yahoo! Finance]

NRX Pharmaceuticals, Inc.  (NRXP) 
PDF Company expects Composition of Matter patent protection Company previously executed joint development agreement with US manufacturer of insulin pumps RADNOR, Pa. Ap [Read more]